Skip to main content
. 2022 Mar 18;143(2):1031–1039. doi: 10.1007/s00402-022-04414-4

Table 1.

Articles included

PJI UKAs (pts) Population age (years) Time UKA—PJI symptoms (days) Infection type Initial treatment Survival rate with no reoperation for infection Survival rate with no reoperation for any cause Mean FU (years)
Group A
 Chalmers et al. [14] 21 (21) 66 (51–87) 199.9 ± 321.0 14 (67%) acute postop 16 (76%) DAIR

76%

(2 years FU)

57%

(5 years FU)

3

(1–9)

3 (14%) acute hematog 4 (19%) 2SE
4 (19%) chronic 1 (5%) 1SE
 Hernandez et al. [19] 15 (15) 58 (41–82) 287.1 ± 571.5 5 (33.3%) acute postop 11 (73.3%) DAIR

71%

(5 years FU)

49%

(5 years FU)

4

(2–6)

5 (33.3%) acute hematog 4 (26.7%) 2SE
5 (33.3%) chronic
 Labruyere et al. [20] 9 (9) 67 (36–83) 9 (100%) chronic 5 (55.6%) DAIR 55.6% 55.6%

5

(3–8)

4 (44.4%) 1SE
Group B
 Burger et al. [22] 1 (1) 1SE 100% 100%
 Mohammad et al. [23] 3 (3) 1 (33%) Arthroscopic debridement and washout 33% 33%
2 (66%) DAIR
 Pandit et al. [24] 6 (5) 6 (100%) 2SE 100% 100%
 Price et al. [25] 5 (5) 5 (100%) 1SE 100% 100%
 Saxler et al. [26] 1 (1) 1 (100%) Synoviectomy and Gentamicin Chain 100% 100%
 Singer et al. [21] 6 (6) 6 (100%) 1SE 100% 100%
 Winnock de Grave et al. [27] 4 (4) 4 (100%) 2SE 100% 100%
 Xue et al. [28] 2 (2) 2 (100%) 2SE 100% 100%

DAIR debridement and implant retention, FU follow-up, PJI periprosthetic joint infection, Preop preoperative, TKA total knee arthroplasty, 1SE one-stage revision procedures, 2SE two-stage revision procedures, (-) not reported